Gary Nabel, ModeX Therapeutics CEO (Rob Tannenbaum for Endpoints News)
March 8, 2023 10:46 AM ESTUpdated 11:06 AM
Deals
Pharma

Ex-NIH, Sanofi lead­ers nab Mer­ck sup­port for their biotech’s Ep­stein-Barr vac­cine 

Kyle LaHucik

Senior Reporter

Gary Nabel, An­tho­ny Fau­ci and oth­er NIH lead­ers called for a vac­cine to pre­vent Ep­stein-Barr virus-as­so­ci­at­ed can­cers in 2011. Nabel went …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump’s sci­ence crack­down hits rare dis­ease re­search: ‘We need to sit down with Elon Musk’

At least sev­en drug­mak­ers say they will par­tic­i­pate in round two of IRA ne­go­ti­a­tions 

Ab­b­Vie fi­nal­ly en­ters obe­si­ty race with $350M up­front for Gubra’s amylin

Ex­clu­sive: In­fec­tious dis­ease doc­tors con­sid­er 'mi­ni-ACIP' if RFK erodes CDC vac­cine pan­el

Lil­ly joins mol­e­c­u­lar glue field with Mag­net deal worth up to $1.25B

sponsored

The per­fect storm: Why every­thing is in place for 2025 to be the year of GxP AI

A service from the Financial Times